-
Bardina SV, Bunduc P, Tripathi S, Duehr J, Frere JJ, Brown JA, Nachbagauer R, Foster GA, Krysztof D, Tortorella D, Stramer SL, Garcia-Sastre A, Krammer F, Lim JK, 2017: Enhancement of Zika virus pathogenesis by preexisting antiflavivirus immunity[J]. Science, 356, 175-180. doi: 10.1126/science.aal4365
-
Baum A, Fulton BO, Wloga E, Copin R, Pascal KE, Russo V, Giordano S, Lanza K, Negron N, Ni M, Wei Y, Atwal GS, Murphy AJ, Stahl N, Yancopoulos GD, Kyratsous CA, 2020: Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies[J]. Science, 369, 1014-1018. doi: 10.1126/science.abd0831
-
Corbett KS, Edwards DK, Leist SR, Abiona OM, Boyoglu-Barnum S, Gillespie RA, Himansu S, Schafer A, Ziwawo CT, DiPiazza AT, Dinnon KH, Elbashir SM, Shaw CA, Woods A, Fritch EJ, Martinez DR, Bock KW, Minai M, Nagata BM, Hutchinson GB, Wu K, Henry C, Bahl K, Garcia-Dominguez D, Ma L, Renzi I, Kong WP, Schmidt SD, Wang L, Zhang Y, Phung E, Chang LA, Loomis RJ, Altaras NE, Narayanan E, Metkar M, Presnyak V, Liu C, Louder MK, Shi W, Leung K, Yang ES, West A, Gully KL, Stevens LJ, Wang N, Wrapp D, Doria-Rose NA, Stewart-Jones G, Bennett H, Alvarado GS, Nason MC, Ruckwardt TJ, McLellan JS, Denison MR, Chappell JD, Moore IN, Morabito KM, Mascola JR, Baric RS, Carfi A, Graham BS, 2020a: SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness[J]. Nature, 586, 567-571. doi: 10.1038/s41586-020-2622-0
-
Corbett KS, Flynn B, Foulds KE, Francica JR, Boyoglu-Barnum S, Werner AP, Flach B, O'Connell S, Bock KW, Minai M, Nagata BM, Andersen H, Martinez DR, Noe AT, Douek N, Donaldson MM, Nji NN, Alvarado GS, Edwards DK, Flebbe DR, Lamb E, Doria-Rose NA, Lin BC, Louder MK, O'Dell S, Schmidt SD, Phung E, Chang LA, Yap C, Todd JM, Pessaint L, Van Ry A, Browne S, Greenhouse J, Putman-Taylor T, Strasbaugh A, Campbell TA, Cook A, Dodson A, Steingrebe K, Shi W, Zhang Y, Abiona OM, Wang L, Pegu A, Yang ES, Leung K, Zhou T, Teng IT, Widge A, Gordon I, Novik L, Gillespie RA, Loomis RJ, Moliva JI, Stewart-Jones G, Himansu S, Kong WP, Nason MC, Morabito KM, Ruckwardt TJ, Ledgerwood JE, Gaudinski MR, Kwong PD, Mascola JR, Carfi A, Lewis MG, Baric RS, McDermott A, Moore IN, Sullivan NJ, Roederer M, Seder RA, Graham BS, 2020b: Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates[J]. N Engl J Med, 383, 1544-1555. doi: 10.1056/NEJMoa2024671
-
Dagotto G, Yu J, Barouch DH, 2020: Approaches and challenges in SARS-CoV-2 vaccine development[J]. Cell Host Microbe, 28, 364-370. doi: 10.1016/j.chom.2020.08.002
-
Duan K, Liu B, Li C, Zhang H, Yu T, Qu J, Zhou M, Chen L, Meng S, Hu Y, Peng C, Yuan M, Huang J, Wang Z, Yu J, Gao X, Wang D, Yu X, Li L, Zhang J, Wu X, Li B, Xu Y, Chen W, Peng Y, Hu Y, Lin L, Liu X, Huang S, Zhou Z, Zhang L, Wang Y, Zhang Z, Deng K, Xia Z, Gong Q, Zhang W, Zheng X, Liu Y, Yang H, Zhou D, Yu D, Hou J, Shi Z, Chen S, Chen Z, Zhang X, Yang X, 2020: Effectiveness of convalescent plasma therapy in severe COVID-19 patients[J]. Proc Natl Acad Sci USA, 117, 9490-9496. doi: 10.1073/pnas.2004168117
-
Gao Q, Bao L, Mao H, Wang L, Xu K, Yang M, Li Y, Zhu L, Wang N, Lv Z, Gao H, Ge X, Kan B, Hu Y, Liu J, Cai F, Jiang D, Yin Y, Qin C, Li J, Gong X, Lou X, Shi W, Wu D, Zhang H, Zhu L, Deng W, Li Y, Lu J, Li C, Wang X, Yin W, Zhang Y, Qin C, 2020: Development of an inactivated vaccine candidate for SARS-CoV-2[J]. Science, 369, 77-81. doi: 10.1126/science.abc1932
-
Graham BS, 2011: Biological challenges and technological opportunities for respiratory syncytial virus vaccine development[J]. Immunol Rev, 239, 149-166. doi: 10.1111/j.1600-065X.2010.00972.x
-
Hoffmann M, Kleine-Weber H, Schroeder S, Kruger N, Herrler T, Erichsen S, Schiergens TS, Herrler G, Wu NH, Nitsche A, Muller MA, Drosten C, Pohlmann S, 2020: SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and Is blocked by a clinically proven protease inhibitor[J]. Cell, 181, 271-280. doi: 10.1016/j.cell.2020.02.052
-
Jiang RD, Liu MQ, Chen Y, Shan C, Zhou YW, Shen XR, Li Q, Zhang L, Zhu Y, Si HR, Wang Q, Min J, Wang X, Zhang W, Li B, Zhang HJ, Baric RS, Zhou P, Yang XL, Shi ZL, 2020: Pathogenesis of SARS-CoV-2 in transgenic mice expressing human angiotensin-converting enzyme 2[J]. Cell, 182, 50-58. doi: 10.1016/j.cell.2020.05.027
-
Katzelnick LC, Gresh L, Halloran ME, Mercado JC, Kuan G, Gordon A, Balmaseda A, Harris E, 2017: Antibody-dependent enhancement of severe dengue disease in humans[J]. Science, 358, 929-932. doi: 10.1126/science.aan6836
-
Kissler SM, Tedijanto C, Goldstein E, Grad YH, Lipsitch M, 2020: Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period[J]. Science, 368, 860-868. doi: 10.1126/science.abb5793
-
Lundstrom K, 2015: RNA-based drugs and vaccines[J]. Expert Rev Vaccines, 14, 253-263. doi: 10.1586/14760584.2015.959932
-
Luo F, Liao FL, Wang H, Tang HB, Yang ZQ, Hou W, 2018: Evaluation of antibody-dependent enhancement of SARS-CoV infection in rhesus macaques immunized with an inactivated SARS-CoV vaccine[J]. Virol Sin, 33, 201-204. doi: 10.1007/s12250-018-0009-2
-
Menachery VD, Yount BL Jr, Sims AC, Debbink K, Agnihothram SS, Gralinski LE, Graham RL, Scobey T, Plante JA, Royal SR, Swanstrom J, Sheahan TP, Pickles RJ, Corti D, Randell SH, Lanzavecchia A, Marasco WA, Baric RS, 2016: SARS-like WIV1-CoV poised for human emergence[J]. Proc Natl Acad Sci USA, 113, 3048-3053. doi: 10.1073/pnas.1517719113
-
Plotkin S, 2014: History of vaccination[J]. Proc Natl Acad Sci USA, 111, 12283-12287. doi: 10.1073/pnas.1400472111
-
Plotkin SA, Plotkin SL, 2011: The development of vaccines: how the past led to the future[J]. Nat Rev Microbiol, 9, 889-893. doi: 10.1038/nrmicro2668
-
Porter KR, Raviprakash K, 2017: DNA vaccine delivery and improved immunogenicity[J]. Curr Issues Mol Biol, 22, 129-138.
-
Shan C, Yao YF, Yang XL, Zhou YW, Gao G, Peng Y, Yang L, Hu X, Xiong J, Jiang RD, Zhang HJ, Gao XX, Peng C, Min J, Chen Y, Si HR, Wu J, Zhou P, Wang YY, Wei HP, Pang W, Hu ZF, Lv LB, Zheng YT, Shi ZL, Yuan ZM, 2020: Infection with novel coronavirus (SARS-CoV-2) causes pneumonia in Rhesus macaques[J]. Cell Res, 30, 670-677. doi: 10.1038/s41422-020-0364-z
-
Stewart AJ, Devlin PM, 2006: The history of the smallpox vaccine[J]. J Infect, 52, 329-334. doi: 10.1016/j.jinf.2005.07.021
-
Tostanoski LH, Wegmann F, Martinot AJ, Loos C, McMahan K, Mercado NB, Yu J, Chan CN, Bondoc S, Starke CE, Nekorchuk M, Busman-Sahay K, Piedra-Mora C, Wrijil LM, Ducat S, Custers J, Atyeo C, Fischinger S, Burke JS, Feldman J, Hauser BM, Caradonna TM, Bondzie EA, Dagotto G, Gebre MS, Jacob-Dolan C, Lin Z, Mahrokhian SH, Nampanya F, Nityanandam R, Pessaint L, Porto M, Ali V, Benetiene D, Tevi K, Andersen H, Lewis MG, Schmidt AG, Lauffenburger DA, Alter G, Estes JD, Schuitemaker H, Zahn R, Barouch DH, 2020: Ad26 vaccine protects against SARS-CoV-2 severe clinical disease in hamsters[J]. Nat Med, 26, 1694-1700. doi: 10.1038/s41591-020-1070-6
-
van Doremalen N, Lambe T, Spencer A, Belij-Rammerstorfer S, Purushotham JN, Port JR, Avanzato VA, Bushmaker T, Flaxman A, Ulaszewska M, Feldmann F, Allen ER, Sharpe H, Schulz J, Holbrook M, Okumura A, Meade-White K, Perez-Perez L, Edwards NJ, Wright D, Bissett C, Gilbride C, Williamson BN, Rosenke R, Long D, Ishwarbhai A, Kailath R, Rose L, Morris S, Powers C, Lovaglio J, Hanley PW, Scott D, Saturday G, de Wit E, Gilbert SC, Munster VJ, 2020: ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques[J]. Nature, 586, 578-582. doi: 10.1038/s41586-020-2608-y
-
Wang H, Zhang Y, Huang B, Deng W, Quan Y, Wang W, Xu W, Zhao Y, Li N, Zhang J, Liang H, Bao L, Xu Y, Ding L, Zhou W, Gao H, Liu J, Niu P, Zhao L, Zhen W, Fu H, Yu S, Zhang Z, Xu G, Li C, Lou Z, Xu M, Qin C, Wu G, Gao GF, Tan W, Yang X, 2020: Development of an inactivated vaccine candidate, BBIBP-CorV, with potent protection against SARS-CoV-2[J]. Cell, 182, 713-721. doi: 10.1016/j.cell.2020.06.008
-
Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M, Shi Z, Hu Z, Zhong W, Xiao G, 2020: Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro[J]. Cell Res, 30, 269-271. doi: 10.1038/s41422-020-0282-0
-
Wang ZJ, Zhang HJ, Lu J, Xu KW, Peng C, Guo J, Gao XX, Wan X, Wang WH, Shan C, Zhang SC, Wu J, Yang AN, Zhu Y, Xiao A, Zhang L, Fu L, Si HR, Cai Q, Yang XL, You L, Zhou YP, Liu J, Pang DQ, Jin WP, Zhang XY, Meng SL, Sun YX, Desselberger U, Wang JZ, Li XG, Duan K, Li CG, Xu M, Shi ZL, Yuan ZM, Yang XM, Shen S, 2020: Low toxicity and high immunogenicity of an inactivated vaccine candidate against COVID-19 in different animal models[J]. Emerg Microbes Infect, 9, 2606-2618. doi: 10.1080/22221751.2020.1852059
-
WHO (2020a) Coronavirus disease (COVID-2019) situation reports.
-
Xia S, Duan K, Zhang Y, Zhao D, Zhang H, Xie Z, Li X, Peng C, Zhang Y, Zhang W, Yang Y, Chen W, Gao X, You W, Wang X, Wang Z, Shi Z, Wang Y, Yang X, Zhang L, Huang L, Wang Q, Lu J, Yang Y, Guo J, Zhou W, Wan X, Wu C, Wang W, Huang S, Du J, Meng Z, Pan A, Yuan Z, Shen S, Guo W, Yang X, 2020: Effect of an inactivated vaccine against SARS-CoV-2 on safety and immunogenicity outcomes: interim analysis of 2 randomized clinical trials[J]. JAMA, 324, 951-960. doi: 10.1001/jama.2020.15543
-
Yang J, Wang W, Chen Z, Lu S, Yang F, Bi Z, Bao L, Mo F, Li X, Huang Y, Hong W, Yang Y, Zhao Y, Ye F, Lin S, Deng W, Chen H, Lei H, Zhang Z, Luo M, Gao H, Zheng Y, Gong Y, Jiang X, Xu Y, Lv Q, Li D, Wang M, Li F, Wang S, Wang G, Yu P, Qu Y, Yang L, Deng H, Tong A, Li J, Wang Z, Yang J, Shen G, Zhao Z, Li Y, Luo J, Liu H, Yu W, Yang M, Xu J, Wang J, Li H, Wang H, Kuang D, Lin P, Hu Z, Guo W, Cheng W, He Y, Song X, Chen C, Xue Z, Yao S, Chen L, Ma X, Chen S, Gou M, Huang W, Wang Y, Fan C, Tian Z, Shi M, Wang FS, Dai L, Wu M, Li G, Wang G, Peng Y, Qian Z, Huang C, Lau JY, Yang Z, Wei Y, Cen X, Peng X, Qin C, Zhang K, Lu G, Wei X, 2020: A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity[J]. Nature, 586, 572-577. doi: 10.1038/s41586-020-2599-8
-
Yu J, Tostanoski LH, Peter L, Mercado NB, McMahan K, Mahrokhian SH, Nkolola JP, Liu J, Li Z, Chandrashekar A, Martinez DR, Loos C, Atyeo C, Fischinger S, Burke JS, Slein MD, Chen Y, Zuiani A, Lelis FJN, Travers M, Habibi S, Pessaint L, Van Ry A, Blade K, Brown R, Cook A, Finneyfrock B, Dodson A, Teow E, Velasco J, Zahn R, Wegmann F, Bondzie EA, Dagotto G, Gebre MS, He X, Jacob-Dolan C, Kirilova M, Kordana N, Lin Z, Maxfield LF, Nampanya F, Nityanandam R, Ventura JD, Wan H, Cai Y, Chen B, Schmidt AG, Wesemann DR, Baric RS, Alter G, Andersen H, Lewis MG, Barouch DH, 2020: DNA vaccine protection against SARS-CoV-2 in rhesus macaques[J]. Science, 369, 806-811. doi: 10.1126/science.abc6284
-
Zhang C, Zhou DM, 2016: Adenoviral vector-based strategies against infectious disease and cancer[J]. Human Vaccin Immunother, 12, 2064-2074. doi: 10.1080/21645515.2016.1165908
-
Zheng HY, Zhang M, Yang CX, Zhang N, Wang XC, Yang XP, Dong XQ, Zheng YT, 2020: Elevated exhaustion levels and reduced functional diversity of T cells in peripheral blood may predict severe progression in COVID-19 patients[J]. Cell Mol Immunol, 17, 541-543. doi: 10.1038/s41423-020-0401-3
-
Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, Si HR, Zhu Y, Li B, Huang CL, Chen HD, Chen J, Luo Y, Guo H, Jiang RD, Liu MQ, Chen Y, Shen XR, Wang X, Zheng XS, Zhao K, Chen QJ, Deng F, Liu LL, Yan B, Zhan FX, Wang YY, Xiao GF, Shi ZL, 2020: A pneumonia outbreak associated with a new coronavirus of probable bat origin[J]. Nature, 579, 270-273. doi: 10.1038/s41586-020-2012-7